On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...

Health insurance rules capping monthly out-of-pocket costs for insulin, asthma inhalers, and epinephrine injectors took effect on New Year’s Day. The provisions, required under a law Gov. Phil Murphy ...

Objective To compare the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once daily dry powder inhaler, ...

this eliminates all the guesswork and uncertainty about how much medicine is left in an inhaler. For example, Ventolin HFA, Advair HFA, and fluticasone have dose counters, Some asthma inhalers do not ...

Asthma inhalers are hand-held devices that allow you to inhale ... MDIs can recognized by the abbreviation HFA (which stands for the propellant hydrofluoroalkane). These include Ventolin HFA, ...

Cumulative propellant loss as a function of study duration for Proventil HFA and Ventolin HFA metered-dose inhalers. Albuterol dose per actuation as a function of temperature for Proventil HFA ...

Amneal beats Teva’s challenge of ruling on some ProAir patents Decision could impact other ‘junk device listings,’ FTC says Five patents related to Teva Pharmaceutical Industries Ltd.’s ProAir HFA ...

Teva alleged that the patents cover aspects of Teva’s ProAir ® HFA (albuterol sulfate) Inhalation Aerosol. Amneal filed an ANDA application, including a Paragraph IV certification, asserting ...

Hannah Garden-Monheit, the director of the FTC's Office of Policy Planning, said in a statement that the decision was "important not only for lowering asthma inhaler costs, it also sets the stage ...

More than 800 schools across Arizona are enrolled in the program, which gives each school one albuterol inhaler and 10 spacers for administering the medication. "Thanks to Lowe's efforts ...

The Stock Inhaler for Schools program is a school-based stock albuterol program in Arizona that was launched in 2017 by researchers at the U of A Health Sciences in collaboration with Banner ...

The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca ...